Firm HCS
Firm HCS
  • Home
  • Team
  • CRITERIA
  • CONTACT
  • Healthcare Reimagined
  • More
    • Home
    • Team
    • CRITERIA
    • CONTACT
    • Healthcare Reimagined

  • Home
  • Team
  • CRITERIA
  • CONTACT
  • Healthcare Reimagined

Investment Profile

Funding Profile

EBITDA RANGE

$5 - $50 Million

Our target companies have meaningful growth potential, sustainable differentiation or value proposition

TRANSACTIONS

Change of control, majority or minority positions with management control, divestitures and family owned businesses seeking liquidity


Use of Proceeds

Growth

Organic growth,

Balance sheet deleveraging,

Acquisitions,

Recapitalization,

Management led buyouts, M&A

Investment Cycles

We are long-term partners and are most focused on achieving the maximum potential of a business.


Region

US & International

United States, although some operations and acquisitions may be abroad

All terms are negotiable

Copyright © 2018 Firm HCS - All Rights Reserved.


Powered by Firm Technologies